Great Novel Therapeutics Biotech & Medicals

TPEX:7427 Stock Report

Market Cap: NT$1.5b

Great Novel Therapeutics Biotech & Medicals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chia-Nan Chen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8.9yrs
CEO ownership3.9%
Management average tenureno data
Board average tenure3.6yrs

Recent management updates

Recent updates

CEO

Chia-Nan Chen

8.9yrs

Tenure

Dr. Chia-Nan Chen serves as Chairman and President of Great Novel Therapeutics Biotech & Medicals (formerly known as GNT Biotech & Medicals Corporation). In 2013, Dr. Chen was one of the founders of GNTbm....

Board Members

NamePositionTenureCompensationOwnership
Chia-Nan Chen
President & Chairman of the Board8.9yrsno data3.86%
NT$ 58.8m
Chung-Yang Huang
Directorno datano data3.1%
NT$ 47.2m
Hung-Jen Wu
Directorno datano data2.33%
NT$ 35.5m
Tonggui Chen
Supervisorno datano datano data
Gary T. Tseng
Director3.6yrsno datano data
Johnsea Chen
Independent Directorno datano datano data
Hung-hui Cheng
Independent Directorno datano datano data
Shang-Pwu Shia
Independent Directorno datano datano data
Hsiu-Chen Chiu
Independent Director1.9yrsno datano data

3.6yrs

Average Tenure

Experienced Board: 7427's board of directors are considered experienced (3.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 01:39
End of Day Share Price 2024/12/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Great Novel Therapeutics Biotech & Medicals is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution